Hypertension Detection and Follow-up Program (HDFP)

Clinical Trial ID NCT00000485

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00000485

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1979 5.72
2 The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group. Prev Med 1976 3.57
3 Evaluation of performance of selected devices for measuring blood pressure. Am J Cardiol 1973 2.45
4 Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989 2.29
5 Variability of blood pressure and the results of screening in the hypertension detection and follow-up program. J Chronic Dis 1978 2.02
6 Impact of hypertension information on high blood pressure control between 1973 and 1978. Hypertension 1980 1.98
7 Hypertension in the inner city. II. Detection and follow-up. Circulation 1973 1.97
8 Relation of serum vitamins A and E and carotenoids to the risk of cancer. N Engl J Med 1984 1.68
9 Mortality findings for stepped-care and referred-care participants in the hypertension detection and follow-up program, stratified by other risk factors. The Hypertension Detection and Follow-up Program Cooperative Research Group. Prev Med 1985 1.60
10 Prediagnostic serum selenium and risk of cancer. Lancet 1983 1.54
11 Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1979 1.49
12 Race, education and prevalence of hypertension. Am J Epidemiol 1977 1.44
13 A coordinating center in a clinical trial: the Hypertension Detection and Followup Program. Control Clin Trials 1983 1.36
14 Educational level and 5-year all-cause mortality in the Hypertension Detection and Follow-up Program. Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1987 1.28
15 Disability days associated with detection and treatment in a hypertension control program. Am J Epidemiol 1984 1.28
16 Blood pressure studies in 14 communities. A two-stage screen for hypertension. JAMA 1977 1.27
17 Clinic attendance in the hypertension detection and follow-up program. Hypertension 1982 1.22
18 Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1982 1.20
19 Correlates of attendance and compliance in the hypertension detection and follow-up program. Control Clin Trials 1982 1.14
20 Three-year incidence of hypertension in thirteen U.S. communities. On behalf of the Hypertension Detection and Follow-up Program cooperative group. Prev Med 1982 1.14
21 Long-term surveillance for adverse effects of antihypertensive drugs. JAMA 1985 1.13
22 High blood pressure: its care and consequences in urban centres. Int J Epidemiol 1974 1.09
23 The association of postural changes in systolic blood pressure and mortality in persons with hypertension: the Hypertension Detection and Follow-up Program experience. Circulation 1987 1.06
24 Improving trend in hypertension control in a black inner city community. Am J Epidemiol 1978 1.06
25 Serum cholesterol and cancer in the Hypertension Detection and Follow-up Program. Cancer 1983 1.06
26 A study of hypertension in a black urban community: preliminary epidemiologic findings. Prev Med 1974 1.05
27 Recent status of detection, treatment, and control of hypertension in the community. J Community Health 1979 1.04
28 Five-year findings of the Hypertension Detection and Follow-up Program. Prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1985 1.04
29 Why do lean hypertensives have higher mortality rates than other hypertensives? Findings of the Hypertension Detection and Follow-up Program. Hypertension 1991 1.02
30 Hypertension detection and follow-up program. Baseline electrocardiographic characteristics of the hypertensive participants. Hypertension 1984 0.99
31 Black-white comparison of indices of coronary heart disease and myocardial infarction in the stepped-care cohort of the Hypertension Detection and Follow-Up Program. Am Heart J 1984 0.98
32 Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program. Arch Intern Med 1985 0.98
33 The relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension. J Chronic Dis 1985 0.96
34 Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1988 0.93
35 The impact of selected indices of antihypertensive treatment on all-cause mortality. Am J Epidemiol 1983 0.91
36 Cardiovascular morbidity and mortality in HDFP patients 50-69 years old at entry. J Cardiovasc Pharmacol 1985 0.91
37 Planning case-finding activities for a community hypertension-control program. Bull N Y Acad Med 1976 0.90
38 Target organ damage in black hypertensives. Circulation 1977 0.90
39 Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris. 5-Year findings of the hypertension detection and follow-up program. Hypertension 1984 0.89
40 A hypertension control program based on the workplace. Report on the Chicago Center. J Occup Med 1978 0.87
41 Five-year findings of the Hypertension Detection and Follow-up Program: mortality by race-sex and blood pressure level. A further analysis. Hypertension Detection and Follow-up Program Cooperative Group. J Community Health 1984 0.87
42 The relation between degree of blood pressure reduction and mortality among hypertensives in the Hypertension Detection and Follow-Up Program. Am J Epidemiol 1988 0.87
43 The relationship between diuretics and serum cholesterol in Hypertension Detection and Follow-up Program participants. Am J Prev Med 1988 0.85
44 Therapeutic control of blood pressure in the Hypertension Detection and Follow-up Program. Hypertension Detection and Follow-up Program Cooperative Group. Prev Med 1979 0.84
45 Mild hypertensives in the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Cooperative Group. Ann N Y Acad Sci 1978 0.83
46 Mortality patterns among hypertensives by reported level of caffeine consumption. Prev Med 1988 0.82
47 Hypertension detection and follow-up program. Summary of the baseline characteristics of the hypertensive participants. Hypertension 1984 0.82
48 The Hypertension Detection and Follow-up Program design, methods, and baseline characteristics and blood pressure response of the study population. Prog Cardiovasc Dis 1987 0.82
49 All-cause mortality in the Hypertension Detection and Follow-up Program: findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality. Prog Cardiovasc Dis 1987 0.82
50 Mortality findings beyond five years in the hypertension detection and follow-up program (HDFP). J Hypertens Suppl 1988 0.81
51 Systolic blood pressure as an independent predictor of mortality in the Hypertension Detection and Follow-up Program. Am J Prev Med 1988 0.81
52 Reserpine and breast cancer in the Hypertension Detection and Follow-Up Program. Hypertension 1982 0.81
53 The hypertension detection and follow-up program: a progress report. Circ Res 1977 0.80
54 Further analyses of the hypertension detection and follow-up program. Drugs 1986 0.79
55 Adverse effects of antihypertensive medications in the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis 1987 0.78
56 Estimated community impact of hypertension control in a high risk population. Am J Epidemiol 1979 0.78
57 Patient-perceived side effects to antihypertensive drugs. Am J Prev Med 1988 0.78
58 Coffee consumption and serum cholesterol in the hypertension detection and follow-up program. Am J Epidemiol 1988 0.77
59 Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis 1987 0.77
60 Antihypertensive drug side effects in the Hypertension Detection and Follow-up Program. Hypertension 1988 0.77
61 Salt intake and the treatment of hypertension. Am Heart J 1977 0.76
62 Effects of labeling and treatment of hypertension on perceived health. Am J Prev Med 1988 0.76
63 Implications of the Hypertension Detection and Follow-up Program. The Hypertension Detection and Follow-up Program Cooperative Group. Prog Cardiovasc Dis 1987 0.75
64 Termination of clinical trials: the beta-blocker heart attack trial and the hypertension detection and follow-up program experience. Control Clin Trials 1985 0.75
65 Cerebrovascular events in the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis 1987 0.75
66 Clinicians' interpretation of the results and implications of the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis 1987 0.75
67 Recruitment in the hypertension detection and follow-up program. Control Clin Trials 1987 0.75
68 The effect of antihypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline: the HDFP experience. The Hypertension Detection and Follow-up Program Cooperative Research Group. Circulation 1984 0.75
69 Hypertension detection and follow-up program. Baseline chest radiographic characteristics of the hypertensive participants. Hypertension 1984 0.75
70 Diet treatment of obese hypertensives. Clin Sci Mol Med Suppl 1973 0.75
71 Hypertension detection and follow-up program. Baseline laboratory examination characteristics of the hypertensive participants. Hypertension 1984 0.75
72 Hypertension detection and follow-up program. Baseline physical examination characteristics of the hypertensive participants. Hypertension 1984 0.75
73 Hypertension detection and follow-up program. Baseline medical history characteristics of the hypertensive participants. Hypertension 1984 0.75
74 Hypertension detection and follow-up program. Description of the enumerated and screened population. Hypertension 1984 0.75
75 Hypertension detection and follow-up program. Baseline characteristics of the enumerated, screened, and hypertensive participants. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1984 0.75
76 Computer-aided management of hypertensive patients. Med Care 1975 0.75
77 Relationship of demographic characteristics of interviewers to blood pressure measurements. J Community Health 1982 0.75
78 Residential mobility and long-term treatment of hypertension. J Community Health 1980 0.75
79 Improving blood pressure normalization. Follow-up of hypertension screening and methodologies. N Y State J Med 1979 0.75
80 A two-compartment regression model applied to compliance in a hypertension treatment program. J Chronic Dis 1980 0.75
81 Two-compartment Markov regression analysis. Comput Programs Biomed 1980 0.75
82 Mortality surveillance in collaborative trials. Am J Public Health 1980 0.75
83 Patient participation in a hypertension control program. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1978 0.75
Next 100